Detalhe da pesquisa
1.
Recombinant vesicular stomatitis vaccine against Nipah virus has a favorable safety profile: Model for assessment of live vaccines with neurotropic potential.
PLoS Pathog
; 18(6): e1010658, 2022 06.
Artigo
em Inglês
| MEDLINE | ID: mdl-35759511
2.
Characterization and Investigation of Risk Factors for Late-Relapsing Hepatitis After Yellow Fever.
Clin Infect Dis
; 77(4): 565-573, 2023 08 22.
Artigo
em Inglês
| MEDLINE | ID: mdl-37099356
3.
A Randomized Dose-Escalating Phase I Trial of a Replication-Deficient Lymphocytic Choriomeningitis Virus Vector-Based Vaccine Against Human Cytomegalovirus.
J Infect Dis
; 225(8): 1399-1410, 2022 04 19.
Artigo
em Inglês
| MEDLINE | ID: mdl-32313928
4.
High Neutralizing Antibody Levels Against Severe Acute Respiratory Syndrome Coronavirus 2 Omicron BA.1 and BA.2 After UB-612 Vaccine Booster.
J Infect Dis
; 226(8): 1401-1406, 2022 10 17.
Artigo
em Inglês
| MEDLINE | ID: mdl-35723969
5.
Immunogenicity and safety of fractional doses of yellow fever vaccines: a randomised, double-blind, non-inferiority trial.
Lancet
; 397(10269): 119-127, 2021 01 09.
Artigo
em Inglês
| MEDLINE | ID: mdl-33422245
6.
A Recombinant Vesicular Stomatitis Virus Ebola Vaccine.
N Engl J Med
; 376(4): 330-341, 2017 01 26.
Artigo
em Inglês
| MEDLINE | ID: mdl-25830322
7.
Comparative evaluation of pathogenicity of three isolates of vesicular stomatitis virus (Indiana serotype) in pigs.
J Gen Virol
; 100(11): 1478-1490, 2019 11.
Artigo
em Inglês
| MEDLINE | ID: mdl-31553299
8.
Biographical Feature: Marc S. Collett (23 May 1951-11 June 2022): the Battle against Viral Disease Has Lost a Valiant Warrior, and the World Has Lost a Splendid Human Being.
J Virol
; 97(1): e0164322, 2023 01 31.
Artigo
em Inglês
| MEDLINE | ID: mdl-36468860
9.
Assessing the safety and immunogenicity of recombinant vesicular stomatitis virus Ebola vaccine in healthy adults: a randomized clinical trial.
CMAJ
; 189(24): E819-E827, 2017 Jun 19.
Artigo
em Inglês
| MEDLINE | ID: mdl-28630358
10.
An inactivated cell-culture vaccine against yellow fever.
N Engl J Med
; 364(14): 1326-33, 2011 Apr 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-21470010
11.
Evaluation of humoral immune response after yellow fever infection: an observational study on patients from the 2017-2018 sylvatic outbreak in Brazil.
Microbiol Spectr
; 12(5): e0370323, 2024 May 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-38511952
12.
Full genomic sequence of the prototype strain (M64) of Rio Bravo virus.
J Virol
; 86(8): 4715, 2012 Apr.
Artigo
em Inglês
| MEDLINE | ID: mdl-22457530
13.
Japanese Encephalitis: Risk of Emergence in the United States and the Resulting Impact.
Viruses
; 16(1)2023 Dec 28.
Artigo
em Inglês
| MEDLINE | ID: mdl-38257754
14.
Immunological correlates of protection afforded by PHV02 live, attenuated recombinant vesicular stomatitis virus vector vaccine against Nipah virus disease.
Front Immunol
; 14: 1216225, 2023.
Artigo
em Inglês
| MEDLINE | ID: mdl-37731485
15.
Yellow fever vaccine supply: a possible solution.
Lancet
; 387(10028): 1599-600, 2016 Apr 16.
Artigo
em Inglês
| MEDLINE | ID: mdl-27116054
16.
Development of antigen-specific memory CD8+ T cells following live-attenuated chimeric West Nile virus vaccination.
J Infect Dis
; 203(4): 513-22, 2011 Feb 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-21216868
17.
Vaccines to Prevent Coccidioidomycosis: A Gene-Deletion Mutant of Coccidioides Posadasii as a Viable Candidate for Human Trials.
J Fungi (Basel)
; 8(8)2022 Aug 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-36012826
18.
Estimation of the Minimal Rift Valley Fever Virus Protective Neutralizing Antibody Titer in Human Volunteers Immunized with MP-12 Vaccine Based on Protection in a Mouse Model of Disease.
Am J Trop Med Hyg
; 107(5): 1091-1098, 2022 11 14.
Artigo
em Inglês
| MEDLINE | ID: mdl-36122681
19.
Transcriptomic signatures induced by the Ebola virus vaccine rVSVΔG-ZEBOV-GP in adult cohorts in Europe, Africa, and North America: a molecular biomarker study.
Lancet Microbe
; 3(2): e113-e123, 2022 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-35544042
20.
A novel RBD-protein/peptide vaccine elicits broadly neutralizing antibodies and protects mice and macaques against SARS-CoV-2.
Emerg Microbes Infect
; 11(1): 2724-2734, 2022 Dec.
Artigo
em Inglês
| MEDLINE | ID: mdl-36287714